Recombinant Spinacia oleracea Defensin D1

Shipped with Ice Packs
In Stock

Description

Antimicrobial Activity

Spinach defensins exhibit potent activity at concentrations <20 µM:

Table 1: Efficacy Against Pathogens

PathogenActivity (EC₅₀, µM)Mechanism
Clavibacter michiganensis (Gram+)1–2Membrane permeabilization
Ralstonia solanacearum (Gram–)11–15Disruption of membrane integrity
Fusarium culmorum0.2–0.3ROS induction, oxidative stress
Colletotrichum lagenarium5–7Binding to fungal glucosylceramide

Data from indicate these defensins target fungal glucosylceramide (GlcCer) and bacterial membrane lipids, triggering reactive oxygen species (ROS) production and membrane depolarization .

Recombinant Production and Functional Insights

While direct studies on recombinant Spinacia oleracea Defensin D1 are absent in the provided sources, methodologies for analogous plant defensins (e.g., Phaseolus vulgaris PvD1 and Raphanus sativus RsAFP2) suggest:

  • Expression Systems: Prokaryotic systems (e.g., E. coli Rosetta strains) with His-tag purification and enterokinase cleavage yield functional peptides .

  • Bioactivity Retention: Recombinant defensins maintain antifungal/antibacterial efficacy comparable to native forms, as shown for PvD1 against Candida albicans .

Mechanism of Action

Group IV defensins act via:

  1. Membrane Interaction: High affinity for ergosterol and GlcCer in fungal membranes, causing pore formation .

  2. Intracellular Effects:

    • ROS overproduction (>30% within 15 minutes at sub-MIC levels) .

    • Disruption of cell cycle regulators (e.g., cyclin F) in eukaryotic pathogens .

Tissue Localization and Biotechnological Potential

These defensins are enriched in spinach epidermal and subepidermal tissues, suggesting roles in pathogen barrier defense . Their stability and low cytotoxicity position them as candidates for:

  • Transgenic crop engineering against bacterial/fungal pathogens.

  • Combinatorial therapies with conventional antibiotics (e.g., synergism with polymyxin B) .

Research Gaps and Future Directions

  • Structural Optimization: Engineering disulfide bonds or loop regions (e.g., L1/L3) to enhance stability .

  • In Vivo Studies: Efficacy validation in plant and animal models against multidrug-resistant pathogens.

Product Specs

Form
Lyophilized powder. We will ship the in-stock format preferentially. If you have specific format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary based on purchase method and location. Contact your local distributor for specific delivery information. All proteins are shipped with standard blue ice packs. Request dry ice shipping in advance; additional fees apply.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receiving. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize developing it.
Synonyms
Defensin D1; Antimicrobial peptide D1; So-D1; Fragment
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-22
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Spinacia oleracea (Spinach)
Target Protein Sequence
XTCESPSHKF KGPCATNRNC ES
Uniprot No.

Target Background

Function
Antimicrobial peptide. Effective against Gram-positive and Gram-negative bacterial pathogens.
Protein Families
DEFL family, Group II subfamily

Q&A

What is Spinacia oleracea Defensin D1 and how is it classified?

Spinacia oleracea Defensin D1 (So-D1) is an antimicrobial peptide isolated from spinach (Spinacia oleracea cv. Matador) leaves. It belongs to the previously described group III of defensins, while other defensins isolated from spinach (So-D2-7) represent a novel structural subfamily (group IV) . Defensins are small, cysteine-rich antimicrobial peptides that form part of plants' innate immune responses .

The classification of plant defensins includes four structural groups which correlate with their antimicrobial activities:

  • Group I: Inhibit Gram-positive bacteria and fungi, with fungal inhibition causing marked hyphal branching

  • Group II: Active against fungi without inducing hyphal branching, and inactive against bacteria

  • Group III (including So-D1): Active against Gram-positive and Gram-negative bacteria but inactive against fungi

  • Group IV (including So-D2-7): Active against both bacteria and fungi, without causing hyphal branching

This classification system suggests that specific determinants within each group target different infectious agents .

What is the antimicrobial spectrum of Spinacia oleracea Defensin D1?

So-D1, as a group III defensin, demonstrates specific antimicrobial activity against both Gram-positive bacteria (such as Clavibacter michiganensis) and Gram-negative bacteria (such as Ralstonia solanacearum), but is inactive against fungi . The antibacterial properties of So-D1 were compared with those of other defensins, including group IV spinach defensins (So-D2,6,7) and another type-III defensin (St-PTH1), as well as Ta-THa thionin .

The following table summarizes the antimicrobial activity profile of So-D1 compared to other defensins:

DefensinBacterial ActivityFungal Activity
So-D1 (Group III)Active against Gram-positive and Gram-negative bacteriaInactive against fungi
So-D2,6,7 (Group IV)Active against Gram-positive and Gram-negative bacteriaActive against Fusarium spp. and other fungi

This selective antimicrobial spectrum highlights the specialized role of So-D1 in plant defense against bacterial pathogens.

How does Spinacia oleracea Defensin D1 differ structurally from other defensins in spinach?

So-D1 belongs to group III defensins, while So-D2-7 belong to group IV defensins. These structural differences correlate with their distinct antimicrobial properties . Although specific structural details of So-D1 are not fully detailed in the available search results, the functional differences between defensin groups suggest variations in:

  • Amino acid sequence composition

  • Three-dimensional protein folding

  • Disulfide bonding patterns

  • Surface charge distribution

The evolution of the defensin peptide family appears congruent with its defense role, as the observed structural and functional divergence could have been driven by different challenges presented by the main pathogens of different plant species . The coexistence of defensins belonging to different subfamilies in the same tissue, as seen with So-D1 and So-D2-7, suggests complementary roles in plant defense .

What is the tissue distribution of Spinacia oleracea Defensin D1 in spinach plants?

While the search results do not provide specific details on the tissue distribution of So-D1 alone, they provide insights into defensin distribution patterns in spinach. Group-IV defensins (So-D2-7) were detected in spinach leaves and stems (but not in roots) at concentrations of 1-3 μmol/kg of fresh weight .

Tissue-print analysis revealed that the distribution of group-IV defensins was primarily peripheral, with higher concentrations in:

  • The epidermal cell layer of leaves

  • A wide subepidermal band in stems

The actual concentrations at deposition sites are estimated to be up to 10-fold higher than in homogenized tissues, well above the concentrations required for inhibition in vitro . Given that So-D1 was isolated from the same crude cell wall preparation as the group IV defensins, it may share similar tissue distribution patterns, though specific studies would be needed to confirm this.

How is the expression of Spinacia oleracea Defensin D1 regulated in response to stress?

While the search results don't provide specific information about So-D1 regulation, research on other plant defensins offers insights into likely regulatory mechanisms. Studies in tomato (Solanum lycopersicum), a different plant species, showed that defensin gene transcription primarily depends on specific pathogen recognition patterns .

For example, tomato defensins showed:

  • Significant upregulation in response to fungal pathogens like Verticillium dahliae

  • Differential responses to nematode infection (Meloidogyne javanica)

  • Minimal induction in response to viral infections (CMV and PVY)

  • Mostly downregulation in response to cold stress

This contrasts with observations from other research teams that recorded defensin induction in response to abiotic stress scenarios, indicating that defensin regulation may be species-specific . For Spinacia oleracea Defensin D1, similar studies examining its expression under different biotic and abiotic stresses would be valuable for understanding its regulation.

What expression systems are most effective for producing recombinant Spinacia oleracea Defensin D1?

For recombinant production of plant defensins like So-D1, several expression systems can be considered, each with advantages and challenges:

  • Bacterial Expression Systems (E. coli):

    • Advantages: Simple, cost-effective, high yield

    • Challenges: Proper disulfide bond formation often requires in vitro refolding

    • Method: Expression as fusion proteins with solubility tags followed by proteolytic cleavage

  • Yeast Expression Systems (Pichia pastoris, Saccharomyces cerevisiae):

    • Advantages: Facilitate proper disulfide bond formation, secretion into medium

    • Challenges: Potential hyperglycosylation, lower yields than bacteria

    • Method: Expression with native or modified secretion signals

  • Plant-Based Expression Systems:

    • Advantages: Native-like post-translational modifications, potentially higher bioactivity

    • Challenges: Lower yields, longer production times

    • Method: Stable transformation or transient expression systems

  • Cell-Free Expression Systems:

    • Advantages: Rapid production, avoid toxicity issues

    • Challenges: Higher cost, potentially lower yields

    • Method: Optimized reaction conditions for disulfide bond formation

The choice of system should be based on the required yield, purity, structural authenticity, and intended application of the recombinant defensin.

How can the antimicrobial activity of recombinant Spinacia oleracea Defensin D1 be accurately assessed?

Antimicrobial activity assessment of recombinant So-D1 should follow standardized methodologies:

  • Bacterial Inhibition Assays:

    • Broth microdilution method to determine Minimum Inhibitory Concentration (MIC)

    • Radial diffusion assays measuring zones of inhibition

    • Time-kill kinetics to assess bactericidal versus bacteriostatic activity

    • Test against relevant Gram-positive bacteria (e.g., Clavibacter michiganensis) and Gram-negative bacteria (e.g., Ralstonia solanacearum)

  • Controls and References:

    • Include positive controls (antibiotics with known activity)

    • Include negative controls (buffer solutions)

    • Compare with native purified So-D1 when possible

    • Include other defensins (e.g., So-D2) for reference

  • Environmental Variables:

    • Test activity under different pH conditions

    • Evaluate the effect of salt concentration (1 mM CaCl₂ + 50 mM KCl have been shown to abolish the activity of some spinach defensins)

    • Assess temperature effects on activity

  • Activity Quantification:

    • Report EC50 values (concentration causing 50% inhibition)

    • Document complete inhibition concentrations

    • Assess dose-dependent relationships

This methodological approach ensures reliable and reproducible assessment of the antimicrobial properties of recombinant So-D1.

How do oxidized and reduced forms of recombinant Spinacia oleracea Defensin D1 differ in their antimicrobial activity?

While specific data on So-D1 oxidation states is not provided in the search results, research on other defensins indicates that the oxidation state can significantly impact antimicrobial activity.

In a study of a cyclic β-defensin analog (AMC), the oxidized and reduced forms showed significantly different antimicrobial activities, with the oxidized form demonstrating superior activity . Additionally, the oxidized form was considerably more stable in human serum .

For recombinant So-D1, the following aspects concerning oxidation states merit investigation:

  • Structural Implications:

    • Oxidized form: Properly formed disulfide bonds, likely resembling the native structure

    • Reduced form: Free sulfhydryl groups, potentially altered three-dimensional structure

  • Activity Assessment:

    • Compare MIC values of oxidized versus reduced forms against bacterial panels

    • Evaluate kinetics of antimicrobial action for both forms

    • Assess stability under various storage and experimental conditions

  • Methodological Considerations:

    • Ensure controlled oxidation conditions for consistent disulfide bond formation

    • Verify oxidation state using techniques such as mass spectrometry

    • Maintain appropriate redox conditions during activity assays

Understanding these differences would provide valuable insights into the structure-function relationship of So-D1 and guide proper handling of the recombinant protein for research applications.

What structural features of Spinacia oleracea Defensin D1 are essential for its antibacterial activity?

Although the search results don't provide specific structural details of So-D1, understanding the structure-function relationship of defensins is crucial for research applications. Several techniques and approaches can be used to determine essential structural features:

  • Structural Analysis Techniques:

    • Nuclear Magnetic Resonance (NMR) spectroscopy for solution structure determination

    • X-ray crystallography if the protein can be crystallized

    • Circular dichroism (CD) spectroscopy for secondary structure content

    • Mass spectrometry for disulfide bond mapping

  • Structure-Function Studies:

    • Site-directed mutagenesis of specific amino acids

    • Creation of chimeric proteins combining regions from different defensin groups

    • Truncation studies to identify minimal active domains

    • Disulfide bond disruption/rearrangement studies

  • Computational Approaches:

    • Molecular dynamics simulations to study protein-membrane interactions

    • Homology modeling based on related defensins with known structures

    • Docking studies to identify potential binding sites with bacterial targets

These approaches would help identify which structural elements of So-D1 are responsible for its specific activity against bacteria but not fungi, providing insights into its mechanism of action.

Can recombinant Spinacia oleracea Defensin D1 be modified to enhance its antimicrobial properties?

Based on research with other defensins, several strategies could be employed to enhance the antimicrobial properties of recombinant So-D1:

  • Structural Modifications:

    • Cyclization strategies as demonstrated with the AMC defensin analog

    • Strategic amino acid substitutions to enhance positive charge or hydrophobicity

    • Creation of hybrid defensins combining bacterial-targeting determinants of So-D1 with elements from other defensins

  • Fusion Protein Approaches:

    • Conjugation with cell-penetrating peptides

    • Fusion with other antimicrobial domains

    • Addition of targeting moieties for specific pathogens

  • Formulation Strategies:

    • Encapsulation in nanoparticles for enhanced stability and delivery

    • Co-formulation with synergistic antimicrobial agents

    • Development of controlled-release systems

  • Directed Evolution:

    • Phage display to select variants with enhanced antimicrobial activity

    • Error-prone PCR to generate libraries of variants for screening

    • Rational design based on structure-function relationships

The cyclic β-defensin analog AMC demonstrates the feasibility of this approach, as it combines the internal hydrophobic domain of hBD1 and the C-terminal charged region of hBD3 to create a novel peptide with specific antimicrobial properties .

What are the potential synergistic effects of Spinacia oleracea Defensin D1 with other antimicrobial compounds?

The coexistence of defensins from different groups in the same plant tissue suggests potential synergistic relationships in plant defense mechanisms . For recombinant So-D1, several synergistic combinations could be investigated:

  • Combination with Other Plant Defensins:

    • So-D1 (antibacterial) + So-D2-7 (antibacterial and antifungal)

    • Testing fractional inhibitory concentration (FIC) indices to quantify synergy

  • Combination with Other Antimicrobial Peptides:

    • Thionins (mentioned in comparison with So-D1)

    • Other classes of plant antimicrobial peptides (snakins, lipid transfer proteins)

    • Methodology: Checkerboard assays to assess synergistic, additive, or antagonistic effects

  • Combination with Conventional Antibiotics:

    • β-lactams, aminoglycosides, or other antibiotic classes

    • Focus on resistant bacterial strains where synergy would be most valuable

    • Time-kill synergy studies to assess kinetics of combined action

  • Formulation Considerations:

    • Optimal ratios of combined antimicrobials

    • Appropriate delivery systems

    • Stability of complexes

Understanding these synergistic relationships would provide insights into the natural defense mechanisms of plants and potentially lead to novel antimicrobial strategies for agricultural or biomedical applications.

How can the stability of recombinant Spinacia oleracea Defensin D1 be optimized for research applications?

Optimizing stability is crucial for research applications of recombinant So-D1. Several approaches can be considered:

  • Buffer Optimization:

    • pH screening to identify optimal stability conditions

    • Evaluation of different buffer systems

    • Addition of stabilizing excipients (glycerol, sugars, amino acids)

  • Storage Conditions:

    • Temperature stability studies (-80°C, -20°C, 4°C)

    • Freeze-thaw stability assessment

    • Lyophilization protocols with appropriate cryoprotectants

  • Oxidation State Management:

    • Maintaining appropriate redox conditions

    • Addition of reducing agents for reduced form stability

    • Protection from oxidative damage

  • Structural Stabilization:

    • Protein engineering approaches (disulfide bond optimization, surface charge modifications)

    • Cyclization strategies as demonstrated with the AMC defensin analog

    • Fusion with stability-enhancing protein domains

  • Analytical Methods for Stability Assessment:

    • Size exclusion chromatography to monitor aggregation

    • Mass spectrometry to detect chemical modifications

    • Activity assays to confirm functional stability

    • Circular dichroism to monitor structural changes

Research with the cyclic defensin analog AMC showed that the oxidized form was considerably more stable in human serum than the reduced form , suggesting that proper disulfide bond formation is critical for defensin stability.

What methods can be used to study the mechanism of action of Spinacia oleracea Defensin D1?

Understanding the mechanism of action of So-D1 requires a multifaceted approach:

  • Membrane Interaction Studies:

    • Artificial membrane systems (liposomes) with bacterial lipid composition

    • Membrane permeabilization assays using fluorescent dyes

    • Surface plasmon resonance to measure binding kinetics

    • Atomic force microscopy to visualize membrane disruption

  • Cellular Effect Analysis:

    • Transmission electron microscopy to observe morphological changes

    • Flow cytometry to assess membrane potential and viability

    • Bacterial transcriptomics to identify stress responses

    • Metabolomics to detect metabolic disruptions

  • Molecular Target Identification:

    • Pull-down assays with immobilized So-D1

    • Cross-linking studies to capture interaction partners

    • Bacterial mutant libraries to identify resistant strains

    • Computational prediction of potential binding targets

  • Structure-Function Correlation:

    • Testing structure-based hypotheses through mutagenesis

    • Comparison with other group III defensins

    • Investigation of differences from group IV defensins, which have broader activity

These approaches would help elucidate whether So-D1 acts primarily through membrane disruption or through interaction with specific bacterial targets, providing insights into its selective activity against bacteria but not fungi.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.